Multidrug resistance reversal effect of DMC derived from buds of Cleistocalyx operculatus in human hepatocellular tumor xenograft model
Authors:
- 21 July 2011
- journal article
- research article
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 92 (1) , 135-140
Abstract
BACKGROUND: Multidrug resistance (MDR) is a major obstacle in the chemotherapeutic treatment of many human cancers. 2′,4′‐Dihydroxy‐6′‐methoxy‐3′,5′‐dimethylchalcone (DMC) isolated from the buds of Cleistocalyx operculatus (Roxb.) Merr. et Perry (Myrtaceae), was investigated for its reversal effects on cancer cell MDR.RESULTS: A human hepatocellular tumor xenograft model was established with the BEL‐7402/5‐FU cell line. Combined 5‐fluorouracil (5‐FU) and DMC (40 mg kg−1) treatment significantly elevated tumor inhibition rate to 72.2%. DMC could also increase 5‐FU concentrations in tumor tissues and increase caspase‐3 activity. Also, combined therapy resulted in enhanced tumor apoptotic and reduced proliferative activities relative to 5‐FU alone. Examining body weight and other signs of unwanted toxicity of the different treatment groups revealed no significant signs of adverse effects.CONCLUSION: All results suggested that DMC reverses 5‐FU resistance, with a benign side effects profile. Copyright © 2011 Society of Chemical IndustryKeywords
Funding Information
- National Natural Science Foundation of China (30870253)
This publication has 23 references indexed in Scilit:
- Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxideNeuroscience Letters, 2010
- Protective effect of a marine oligopeptide preparation from Chum Salmon (Oncorhynchus keta) on radiation‐induced immune suppression in miceJournal of the Science of Food and Agriculture, 2010
- Spatial variation of intestinal skatole production and microbial community in Jinhua and Landrace pigsJournal of the Science of Food and Agriculture, 2009
- Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuationBMC Cancer, 2008
- S‐Allyl cysteine, S‐ethyl cysteine and S‐propyl cysteine alleviate oxidative stress‐induced damage within PC12 cellsJournal of the Science of Food and Agriculture, 2008
- Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivoJournal of Hepatology, 2005
- Honey‐bee products in prevention and/or therapy of murine transplantable tumoursJournal of the Science of Food and Agriculture, 2004
- In vitro anti-tumor activity of 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone against six established human cancer cell linesPharmacological Research, 2004
- Flavonoids from Cleistocalyx operculatusPhytochemistry, 2004
- Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastasesCancer, 2000